Colonoscopy
Conditions
Interventions
Intravenous administration of Buscopan or 0.9% Natriumchloride Solutution (placebo) during colonoscopy.
No further interventions
The duration of the action of Buscopan
Sponsors
Deventer Hospital (Netherlands)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged 30 years or older 2. Able to understand and give informed consent 3. Routinely referred for colonoscopy
Exclusion criteria
Exclusion criteria: 1. Pregnancy 2. Myasthenia gravis 3. Exacerbation of inflammatory bowel disease 4. Suspicion of ongoing diverticulitis 5. Expectation of an estimated probability of complete colonoscopy of less than 50%, e.g. by the presence of a stenosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of colonoscopies during which at least one polyp has been found divided by the total number of colonoscopies | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Polyp detection score During each colonoscopy the number and shape of the polyps will be recorded. Polyps 10 mm will confer 1 point Scores will be made for flat / broad based polyps as well as rounded / pedunculated polyps. 2. Polyp removal ratio The number of removed polyps divided by the number of detected polyps 3 Pathology retrieval ratio The number of polyps send for pathological investigation divided by the number of removed polyps 4 Influence of age category Categories are: 30 - 50 years, 51 ? 70 years and > 70 years. 5 Influence of diverticulosis category Categories are: 1: 0-2 diverticula, 2: 3-10 diverticula, 3: 11-20 diverticula en 4: > 20 diverticula. 6 Influence of the endocopist | — |
Countries
Netherlands
Outcome results
None listed